HL Acquisitions Corp. (HCCH), which previously announced their intended combination with Fusion Welcome-Fuel, held their shareholder vote today to extend their completion deadline three months to October 2, 2020. The extension was approved, but more importantly, HCCH had a very light number of shareholders redeem, thanks to a share price trading around $12.22, which is well above the estimated cash in trust value of $10.56.
Per today’s 8-K, only 500 ordinary shares exercised their right to redeem at a price of approximately $10.56 per share, for an aggregate conversion amount of just $5,280. This is HCCH’s third extension, but presumably it is its last since it appears the Fusion Welcome-Fuel deal has been well received and this should make it through the proxy process in short order. Current share count (post-extension vote) is now 5,097,516, with an estimated trust value of roughly $53.83 million.
As a reminder, HL Acquisitions will not be making a contribution to trust for extending.
You can review the vote results HERE.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...